Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 4, 2012, Pages 449-457

  Okamura, Yukiyasu ^a,b   Maeda, Atsuyuki ^a   Matsunaga, Kazuya ^a   Kanemoto, Hideyuki ^a   Uesaka, Katsuhiko ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Body mass index; Hepatocellular carcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BILE LEAKAGE; BODY MASS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; OVERALL SURVIVAL; PLEURA EFFUSION; PREDICTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; WOUND INFECTION;

BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; COMORBIDITY; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; OBESITY; PORTAL SYSTEM; PROGNOSIS;

EID: 84867402937     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0461-y     Document Type: Article

References (36)

1. Berkalp B, Cesur V, Corapcioglu D, Erol C, Baskal N. Obesity and left ventricular diastolic dysfunction. Int J Cardiol. 1995;52:23-6.
2. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-60.
3. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631-6.
4. Wolk A, Gridley G, Svensson M, Nyren O, Mclaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13-21.
5. Lew EA, Garfinkle L. Variation in mortality by weight among 75,000 men and women. J Chronic Dis. 1979;32:563-76.
6. Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032-5.
7. Hawn MT, Bian J, Leeth RR, Ritchie G, Allen N, Bland KI, et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg. 2005;241:821-8.
8. Barry JD, Blackshaw GR, Edwards P, Lewis WG, Murphy P, Hodzovic I, et al. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma. Gastric Cancer. 2003;6:80-5.
9. Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J. The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg. 2005;241: 69-76.
10. Tsujinaka T, Sasako M, Yamamoto S, Sano T, Kurokawa Y, Nashimoto A, et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007;14:355-61.
11. Inagawa S, Adachi S, Oda T, Kawamoto T, Koike N, Fukao K. Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer. 2000;3:141-4.
12. Yamanaka H, Nishi M, Kanemaki T, Hosoda N, Hioki K, Yamamoto M. Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients. JPEN. 1989;13:286-91.
13. Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kasaoka C. Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology. 2003;50:284-8.
14. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcome in patients undergoing major intraabdominal cancer surgery. Ann Surg Oncol. 2008;15:2164-72.
15. Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010;14:1285-91.
16. Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH. Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg. 2010;14:849-57.
17. Utsunomiya T, Okamoto M, Kameyama T, Matsuyama A, Yamamoto M, Fujiwara M, et al. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol. 2008;14:1553-8.
18. Caldwell SH, Crespo DM, Kang HS, AI-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:97-103.
19. NIH Consensus Development. Conference: statement II health implications of obesity. Ann Intern Med. 1985;103:1073-7.
20. WHO. Obesity-preventing and managing the global epidemic. Report of WHO consultation on obesity. Geneva; 1997.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
22. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329-36.
23. Mukherjee M, Sahasrabuddhe MB. Effect of operation on peripheral lymphocyte counts and production of adenosine triphosphate (ATP) in cancer patients. J Surg Oncol. 1982;20:1-8.
24. Roth JA, Golub SH, Grimm EA, Eilber FR, Morton DL. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Surgery. 1976;79: 46-51.
25. Sobin LH, Wittekind CH (eds) TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 81-3.
26. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;352:751-5.
27. Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst. 1985;74:319-23.
28. Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW. Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981;67:785-9.
29. Hansson LE, Baron J, Nyrén O, Bergström R, Wolk A, Lindgren A, et al. Early-life risk indicators of gastric cancer. A population based case-control study in Sweden. Int J Cancer. 1991;57:32-7.
30. Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Masunaga R, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59:18-23.
31. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg. 2009;9:1636-42.
32. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43:1295-302.
33. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008;47:1856-62.
34. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134-40.
35. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322-6.
36. Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001;96:1243-50.